Period of time： 2014年2期
Publisher： Informa Healthcare
Founded in： 2002
Total resources： 54
ISSN： 1474-0338
Subject： R9 Pharmacy
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Expert Opinion on Drug Safety,volume 3,issue 2
Menu
Unlicensed and off-label drug use in children: implications for safety
Expert Opinion on Drug Safety,volume 3,issue 2 , Vol. 3, Iss. 2, 2004-03 , pp.
Access to resources
Recommend
Severe colitis after administration of UFT chemotherapy for temporal bone carcinoma
By Akay S,Özütemiz Ö,Doganavsargil B in (2004)
Expert Opinion on Drug Safety,volume 3,issue 2 , Vol. 3, Iss. 2, 2004-03 , pp.By Kociancic Todd,Reed Michael D,Findling Robert L in (2004)
Expert Opinion on Drug Safety,volume 3,issue 2 , Vol. 3, Iss. 2, 2004-03 , pp.The effect of fibrates and other lipid-lowering drugs on plasma homocysteine levels
By Dierkes Jutta,Westphal Sabine,Luley Claus in (2004)
Expert Opinion on Drug Safety,volume 3,issue 2 , Vol. 3, Iss. 2, 2004-03 , pp.The safety of antithrombotic therapy during pregnancy
By Ageno Walter,Crotti Stefania,Turpie Alexander GG in (2004)
Expert Opinion on Drug Safety,volume 3,issue 2 , Vol. 3, Iss. 2, 2004-03 , pp.Safety and side effects of the acne drug, oral isotretinoin
By Charakida A,Mouser PE,Chu AC in (2004)
Expert Opinion on Drug Safety,volume 3,issue 2 , Vol. 3, Iss. 2, 2004-03 , pp.COX inhibitors and their effects on bone healing
By Gerstenfeld Louis C,Einhorn Thomas A in (2004)
Expert Opinion on Drug Safety,volume 3,issue 2 , Vol. 3, Iss. 2, 2004-03 , pp.Molecular profiling approaches for identifying novel biomarkers
By Bailey Wendy J,Ulrich Roger in (2004)
Expert Opinion on Drug Safety,volume 3,issue 2 , Vol. 3, Iss. 2, 2004-03 , pp.Pharmaceutical Stability Testing Conference
By Shi Li,Schofield Timothy in (2004)
Expert Opinion on Drug Safety,volume 3,issue 2 , Vol. 3, Iss. 2, 2004-03 , pp.